These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 5763076)

  • 1. Structure of subtilisin BPN' at 2.5 angström resolution.
    Wright CS; Alden RA; Kraut J
    Nature; 1969 Jan; 221(5177):235-42. PubMed ID: 5763076
    [No Abstract]   [Full Text] [Related]  

  • 2. Subtilisin Novo. The three-dimensional structure and its comparison with subtilisin BPN'.
    Drenth J; Hol WG; Jansonius JN; Koekoek R
    Eur J Biochem; 1972 Mar; 26(2):177-81. PubMed ID: 5046041
    [No Abstract]   [Full Text] [Related]  

  • 3. The aromatic substrate binding site in subtilisin BPN' and its resemblance to chymotrypsin.
    Kraut J; Robertus JD; Birktoft JJ; Alden RA; Wilcox PE; Powers JC
    Cold Spring Harb Symp Quant Biol; 1972; 36():117-23. PubMed ID: 4508128
    [No Abstract]   [Full Text] [Related]  

  • 4. A new substrate and two inhibitors applicable for thermitase, subtilisin BPN' and alpha-chymotrypsin. Comparison of kinetic parameters with customary substrates and inhibitors.
    Brömme D; Fittkau S
    Biomed Biochim Acta; 1985; 44(7-8):1089-94. PubMed ID: 3910035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of an engineered subtilisin inhibitor complexed with bovine trypsin.
    Takeuchi Y; Nonaka T; Nakamura KT; Kojima S; Miura K; Mitsui Y
    Proc Natl Acad Sci U S A; 1992 May; 89(10):4407-11. PubMed ID: 1584773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporation of a stabilizing Ca(2+)-binding loop into subtilisin BPN'.
    Braxton S; Wells JA
    Biochemistry; 1992 Sep; 31(34):7796-801. PubMed ID: 1510966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the three-dimensional structures of subtilisin BPN' and subtilisin novo.
    Drenth J; Hol WG; Jansonius JN; Koekoek R
    Cold Spring Harb Symp Quant Biol; 1972; 36():107-16. PubMed ID: 4508127
    [No Abstract]   [Full Text] [Related]  

  • 8. Crystal structure of thermitase from Thermoactinomyces vulgaris at 2.2 A resolution.
    Teplyakov AV; Kuranova IP; Harutyunyan EH; Frömmel C; Höhne WE
    FEBS Lett; 1989 Feb; 244(1):208-12. PubMed ID: 2647518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of subtilisin BPN' by reaction site P1 mutants of Streptomyces subtilisin inhibitor.
    Kojima S; Nishiyama Y; Kumagai I; Miura K
    J Biochem; 1991 Mar; 109(3):377-82. PubMed ID: 1908859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant chymotrypsin inhibitor 2: expression, kinetic analysis of inhibition with alpha-chymotrypsin and wild-type and mutant subtilisin BPN', and protein engineering to investigate inhibitory specificity and mechanism.
    Longstaff C; Campbell AF; Fersht AR
    Biochemistry; 1990 Aug; 29(31):7339-47. PubMed ID: 2207109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative studies of the specificities of -chymotrypsin and subtilisin BPN'. Studies with flexible and 'locked' substrates.
    Pattabiraman TN; Lawson WB
    Biochem J; 1972 Feb; 126(3):659-65. PubMed ID: 5075272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refined crystal structure of the complex of subtilisin BPN' and Streptomyces subtilisin inhibitor at 1.8 A resolution.
    Takeuchi Y; Satow Y; Nakamura KT; Mitsui Y
    J Mol Biol; 1991 Sep; 221(1):309-25. PubMed ID: 1920411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the active site stereochemistry and substrate conformation in -chymotrypsin and subtilisin BPN'.
    Wright CS
    J Mol Biol; 1972 Jun; 67(1):151-63. PubMed ID: 5064999
    [No Abstract]   [Full Text] [Related]  

  • 14. Variability in the tertiary structure of alpha-chymotrypsin at 2.8-A resolution.
    Tulinsky A; Vandlen RL; Morimoto CN; Mani NV; Wright LH
    Biochemistry; 1973 Oct; 12(21):4185-92. PubMed ID: 4745666
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes in the tertiary structure of alpha-chymotrypsin with change in pH: p4 4.2-6.7.
    Vandlen RL; Tulinsky A
    Biochemistry; 1973 Oct; 12(21):4193-200. PubMed ID: 4745667
    [No Abstract]   [Full Text] [Related]  

  • 16. Designing subtilisin BPN' to cleave substrates containing dibasic residues.
    Ballinger MD; Tom J; Wells JA
    Biochemistry; 1995 Oct; 34(41):13312-9. PubMed ID: 7577915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding, proteolytic, and crystallographic analyses of mutations at the protease-inhibitor interface of the subtilisin BPN'/chymotrypsin inhibitor 2 complex.
    Radisky ES; Kwan G; Karen Lu CJ; Koshland DE
    Biochemistry; 2004 Nov; 43(43):13648-56. PubMed ID: 15504027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of crystalline -chymotrypsin. II. A preliminary report including a hypothesis for the activation mechanism.
    Sigler PB; Blow DM; Matthews BW; Henderson R
    J Mol Biol; 1968 Jul; 35(1):143-64. PubMed ID: 5760561
    [No Abstract]   [Full Text] [Related]  

  • 19. Atomic coordinates for subtilisin BPN' (or Novo).
    Alden RA; Birktoft JJ; Kraut J; Robertus JD; Wright CS
    Biochem Biophys Res Commun; 1971 Oct; 45(2):337-44. PubMed ID: 5160720
    [No Abstract]   [Full Text] [Related]  

  • 20. A hydrogen-bond network at the active site of subtilisin BPN'.
    Alden RA; Wright CS; Kraut J
    Philos Trans R Soc Lond B Biol Sci; 1970 Feb; 257(813):119-24. PubMed ID: 4399039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.